Shares of Ondine Biomedical Inc. (LON:OBI – Get Free Report) shot up 11.7% on Thursday . The company traded as high as GBX 7.49 ($0.10) and last traded at GBX 7.40 ($0.10). 401,926 shares traded hands during trading, an increase of 56% from the average session volume of 257,324 shares. The stock had previously closed at GBX 6.63 ($0.09).
Ondine Biomedical Stock Up 11.7 %
The company has a market capitalization of £20.52 million, a PE ratio of -249.67 and a beta of 0.10. The company has a debt-to-equity ratio of 1,847.37, a quick ratio of 8.26 and a current ratio of 0.80. The company’s 50-day moving average is GBX 6.61 and its 200 day moving average is GBX 7.17.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- What is the Hang Seng index?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Use Stock Screeners to Find Stocks
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Financial Services Stocks Investing
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
